BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30015978)

  • 1. Pin2/TRF1‑binding protein X1 inhibits colorectal cancer cell migration and invasion in vitro and metastasis in vivo via the nuclear factor‑κB signaling pathway.
    Jiang T; Li H; Jiang R; Li H; Hou P; Chen Y; Bai J; Song J
    Oncol Rep; 2018 Sep; 40(3):1533-1544. PubMed ID: 30015978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
    Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
    Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.
    Li HL; Han L; Chen HR; Meng F; Liu QH; Pan ZQ; Bai J; Zheng JN
    Oncotarget; 2015 Aug; 6(25):21406-20. PubMed ID: 26033551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of PinX1 protein predicts poor prognosis of colorectal cancer patients receiving 5-FU adjuvant chemotherapy.
    Deng W; Jiao N; Li N; Wan X; Luo S; Zhang Y
    Biomed Pharmacother; 2015 Jul; 73():1-5. PubMed ID: 26211574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DHX9 contributes to the malignant phenotypes of colorectal cancer via activating NF-κB signaling pathway.
    Liu S; He L; Wu J; Wu X; Xie L; Dai W; Chen L; Xie F; Liu Z
    Cell Mol Life Sci; 2021 Dec; 78(24):8261-8281. PubMed ID: 34773477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RasGRF2 promotes migration and invasion of colorectal cancer cells by modulating expression of MMP9 through Src/Akt/NF-κB pathway.
    Lu P; Chen J; Yan L; Yang L; Zhang L; Dai J; Hao Z; Bai T; Xi Y; Li Y; Kang Z; Xv J; Sun G; Yang T
    Cancer Biol Ther; 2019; 20(4):435-443. PubMed ID: 30359168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
    Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
    J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evodiamine inhibits migration and invasion by Sirt1-mediated post-translational modulations in colorectal cancer.
    Zhou P; Li XP; Jiang R; Chen Y; Lv XT; Guo XX; Tian K; Yuan DZ; Lv YW; Ran JH; Li J; Chen DL
    Anticancer Drugs; 2019 Jul; 30(6):611-617. PubMed ID: 30789361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
    Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
    Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Huang M; Geng Y; Deng Q; Li R; Shao X; Zhang Z; Xu W; Wu Y; Ma Q
    Int J Oncol; 2018 Oct; 53(4):1481-1492. PubMed ID: 30066846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDRG1 predicts a poor prognosis and facilitates the proliferation and metastasis of colorectal cancer.
    Xu Y; Liu J; Jiang T; Shi L; Shang L; Song J; Li L
    Exp Cell Res; 2021 Dec; 409(2):112924. PubMed ID: 34780783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA LINC00052 inhibits colorectal cancer metastasis by sponging microRNA-574-5p to modulate CALCOCO1 expression.
    Yu G; Xiong D; Liu Z; Li Y; Chen K; Tang H
    J Cell Biochem; 2019 Oct; 120(10):17258-17272. PubMed ID: 31104316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
    Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
    Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIM3 Functions as Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer.
    Qi Q; Pan Y; Han S; Liao H; Jiang Y; Shen J; Zhong L; Wang X; Chen J
    Anat Rec (Hoboken); 2019 Sep; 302(9):1552-1560. PubMed ID: 30417983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear division cycle 80 promotes malignant progression and predicts clinical outcome in colorectal cancer.
    Yan X; Huang L; Liu L; Qin H; Song Z
    Cancer Med; 2018 Feb; 7(2):420-432. PubMed ID: 29341479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.